retatrutide glp-1 gip glucagon receptor agonist Retatrutide, a GIP, and agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled, parallel-group, phase 2 trial conducted in the USA Retatrutide 50mg | High Potency

At Kairos Rejuvenation, we are excited to offer three cutting-edge peptidesBPC-157, GHK-Cu, and TB-500designed to support healing, reduce inflammation, and enhance overall well-being

Visible skin benefits follow as oxidative stress decreases and melanin regulation improves

Impact of real-life environmental exposures on reproduction: phthalates disrupt female reproductive health: a call for enhanced investigation into mixtures

What it may help with: Joint and soft-tissue recovery (knee, hip, shoulder, rotator cuff, low back)

In both in vitro and in vivo studies, the ES2 peptide has shown potent senolytic activity with minimal apoptotic effects on non-senescent cancer cells [128]

IGF-1 and insulin as growth hormones [PMID: 15562823] Laboratory literature summary: IGF-1 and insulin as growth hormones